In SLE, the high prevalence of ANA and hypergammaglobulinemia confers that the other diagnostic markers, i.e., SMA antibodies, antibodies against soluble liver antigen (SLA) or LKM, play a more important role for diagnosing AIH. This evidence concerns the gene SMN1 and autoimmune hepatitis.